MarketPeel
Insider Trading Intelligence
JD

Jarrett Disbrow

AYTU
CHIEF BUSINESS OFFICER · AYTU BIOPHARMA, INC · CIK 0001640724
FILING MIX · LIFETIME100%/0%
BUYS
5
SELLS
0
TOTAL VALUE
$25.0K
COMPANIES
1
ACTIVE SINCE
Aug 2023
HOLDINGS NOW
61,568
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jarrett Disbrow, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-6.16%+0.50%-6.66%-6.66%
14d1+0.00%-6.16%+0.08%-6.24%-6.24%
30d1+100.00%+11.85%+4.07%+7.78%+7.78%
60d1+100.00%+12.32%+6.25%+6.07%+6.07%
90d1+100.00%+7.58%+8.20%-0.61%-0.61%
180d1+100.00%+5.21%+14.34%-9.13%-9.13%
1y1+100.00%+8.53%+23.27%-14.74%-14.74%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AYTU · 61,568 shares · as of Oct 3, 2025
015,39230,78446,17661,56820242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 5 buys / 0 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
19,60649,068Oct 3, 2025Oct 7, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
12,50061,568Oct 3, 2025Oct 7, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Business Officer
16,666$1.50$25.0K29,462Jun 9, 2025Jun 10, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
7,0007,000Nov 6, 2024Nov 8, 2024View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
7,0007,000Aug 11, 2023Aug 15, 2023View →
Other insiders · AYTU
Loading peer insiders…
About this filer
CIK 0001640724
ROLE
Chief Business Officer
PRIMARY
AYTU
COMPANIES
1
ACTIVE SINCE
Aug 2023
MARKETPEEL · /INSIDER/0001640724DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback